Search

Displaying results 2481 - 2490 of 7059 in total
  1. Drug

    Bofutrelvir

    go.drugbank.com/drugs/DB21501
    Experimental

    Bofutrelvir has a monoisotopic molecular weight of 452.24 Da. … Bofutrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Bofutrelvir is a antiviral 3CL protease inhibitor.

  2. Drug

    Ulecaciclib

    go.drugbank.com/drugs/DB21595
    Experimental

    Ulecaciclib has a monoisotopic molecular weight of 496.25 Da. … Ulecaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Ulecaciclib is a cyclin dependant kinase inhibitor.

  3. Drug

    Eciruciclib

    go.drugbank.com/drugs/DB21597
    Experimental

    Eciruciclib has a monoisotopic molecular weight of 488.28 Da. … Eciruciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Eciruciclib is a cyclin dependant kinase inhibitor.

  4. Drug

    Zevotrelvir

    go.drugbank.com/drugs/DB21638
    Experimental

    Zevotrelvir has a monoisotopic molecular weight of 537.2 Da. … Zevotrelvir is a small molecule drug. The usage of the INN stem '-trelvir' in the name indicates that Zevotrelvir is a antiviral 3CL protease inhibitor.

  5. Drug

    Orenasitecan

    go.drugbank.com/drugs/DB21718
    Experimental

    Orenasitecan has a monoisotopic molecular weight of 1470.58 Da. … Orenasitecan is a small molecule drug. The usage of the INN stem '-tecan' in the name indicates that Orenasitecan is a antineoplastic, topoisomerase I inhibitor.

  6. Drug

    Mocaciclib

    go.drugbank.com/drugs/DB21730
    Experimental

    Mocaciclib has a monoisotopic molecular weight of 609.3 Da. … Mocaciclib is a small molecule drug. The usage of the INN stem '-ciclib' in the name indicates that Mocaciclib is a cyclin dependant kinase inhibitor.

  7. Drug

    Prasugrel

    go.drugbank.com/drugs/DB06209
    ApprovedInvestigational

    FDA approved in 2009. … Prasugrel, a thienopyridine derivative, is a platelet activation and aggregation inhibitor structurally and pharmacologically related to clopidogrel and ticlopidine.

  8. Drug

    Nelarabine

    go.drugbank.com/drugs/DB01280
    ApprovedInvestigational

    [A2331] Nelarabine is a purine nucleoside analog converted to its corresponding arabinosylguanine nucleotide triphosphate (araGTP), resulting in the inhibition of DNA synthesis and cytotoxicity. … [A2332] Due to the rarity of these T-cell malignancies, nelarabine was first granted orphan drug status and a fast-track designation by the FDA to address the unmet therapeutic needs of these cancers.

    Synonyms: 2-Amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
  9. Drug

    Rifampin

    go.drugbank.com/drugs/DB01045
    ApprovedInvestigational

    [A263768] Rifampin is used to treat tuberculosis and works by inhibiting the microbial DNA-dependent RNA polymerase (RNAP).[A263768] … Rifampin, also known as rifampicin, is a broad-spectrum antimicrobial [A263748] that was first discovered in 1965 [A263753] and clinically used in 1968.

  10. Drug

    Insulin lispro

    go.drugbank.com/drugs/DB00046
    ApprovedInvestigational

    Marketed as the brand name product Humalog, insulin lispro begins to exert its effects within 15 minutes of subcutaneous administration, while peak levels occur 30 to 90 minutes after administration. … Insulin lispro is produced by recombinant DNA technology utilizing a non-pathogenic laboratory strain of Escherichia coli and was the first commercially available insulin analog.